The long-term effects of chemotherapy on normal blood cells
Emily Mitchell(Wellcome Sanger Institute), Michael R. Stratton(Wellcome Sanger Institute), Michael Spencer Chapman(Wellcome Sanger Institute), Aditi Vedi(Wellcome/MRC Cambridge Stem Cell Institute), George Follows(Cambridge University Hospitals NHS Foundation Trust), Laura Humphreys(University of Cambridge), Alex Cagan(Wellcome Sanger Institute), Iñigo Martincorena(Wellcome Sanger Institute), Anna Santarsieri(Cambridge University Hospitals NHS Foundation Trust), Krishnaa T. Mahbubani(University of Cambridge), Raheleh Rahbari(Wellcome Sanger Institute), David G. Kent(University of York), Gary J. Doherty(University of Cambridge), Kourosh Saeb‐Parsy(University of Cambridge), E. Joanna Baxter(University of Cambridge), Daniel J. Hodson(Wellcome/MRC Cambridge Stem Cell Institute), Joanne I. Hsu(Harvard University), Margaret A. Goodell(Baylor College of Medicine), Sandra Pietsch(Wellcome/MRC Cambridge Stem Cell Institute), Ultan McDermott(Wellcome Sanger Institute), Rashesh Sanghvi(Wellcome Sanger Institute), Elisa Laurenti(Wellcome/MRC Cambridge Stem Cell Institute), Jyoti Nangalia(University of Namur), Daniel Leonganmornlert(Wellcome Sanger Institute), Ellie Dunstone(Wellcome/MRC Cambridge Stem Cell Institute), Jingwei Wang(Wellcome Sanger Institute), Sarah Moody(Wellcome Sanger Institute), My H. Pham(Wellcome Sanger Institute), Koichi Takahashi(The University of Texas MD Anderson Cancer Center), Peter J. Campbell(Wellcome Sanger Institute), Hyunchul Jung(Wellcome Sanger Institute), Anna Clay(Babraham Institute), Heather E. Machado(Wellcome Sanger Institute)
Cited by 4
Related Papers
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
The cancer genome
|Nature|2009|3.5k
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
|Nucleic Acids Research|2014|2.4k